Kammula U - Search Results

1

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.

Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, Rogers LJ, Gracia GJ, Jones SA, Mangiameli DP, Pelletier MM, Gea-Banacloche J, Robinson MR, Berman DM, Filie AC, Abati A, Rosenberg SA. Dudley ME, et al. Among authors: kammula u. J Clin Oncol. 2005 Apr 1;23(10):2346-57. doi: 10.1200/JCO.2005.00.240. J Clin Oncol. 2005. PMID: 15800326 Free PMC article. Clinical Trial.

2

Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer.

Kammula US, White DE, Rosenberg SA. Kammula US, et al. Cancer. 1998 Aug 15;83(4):797-805. Cancer. 1998. PMID: 9708948

3

Cancer therapy using a self-replicating RNA vaccine.

Ying H, Zaks TZ, Wang RF, Irvine KR, Kammula US, Marincola FM, Leitner WW, Restifo NP. Ying H, et al. Among authors: kammula us. Nat Med. 1999 Jul;5(7):823-7. doi: 10.1038/10548. Nat Med. 1999. PMID: 10395329 Free PMC article.

4

Immune selection after antigen-specific immunotherapy of melanoma.

Riker A, Cormier J, Panelli M, Kammula U, Wang E, Abati A, Fetsch P, Lee KH, Steinberg S, Rosenberg S, Marincola F. Riker A, et al. Among authors: kammula u. Surgery. 1999 Aug;126(2):112-20. Surgery. 1999. PMID: 10455872

5

Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: advances in the monitoring of patients with metastatic melanoma.

Riker AI, Panelli MC, Kammula US, Wang E, Wunderlich J, Abati A, Fetsch P, Rosenberg SA, Marincola FM. Riker AI, et al. Among authors: kammula us. Cancer Detect Prev. 1999;23(5):387-96. doi: 10.1046/j.1525-1500.1999.99045.x. Cancer Detect Prev. 1999. PMID: 10468890

6

Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens.

Kammula US, Lee KH, Riker AI, Wang E, Ohnmacht GA, Rosenberg SA, Marincola FM. Kammula US, et al. J Immunol. 1999 Dec 15;163(12):6867-75. J Immunol. 1999. PMID: 10586088

7

Expansion of tumor-T cell pairs from fine needle aspirates of melanoma metastases.

Panelli MC, Riker A, Kammula U, Wang E, Lee KH, Rosenberg SA, Marincola FM. Panelli MC, et al. Among authors: kammula u. J Immunol. 2000 Jan 1;164(1):495-504. doi: 10.4049/jimmunol.164.1.495. J Immunol. 2000. PMID: 10605047

8

Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes.

Riker AI, Kammula US, Panelli MC, Wang E, Ohnmacht GA, Steinberg SM, Rosenberg SA, Marincola FM. Riker AI, et al. Among authors: kammula us. Int J Cancer. 2000 Jun 15;86(6):818-26. doi: 10.1002/(sici)1097-0215(20000615)86:6<818::aid-ijc10>3.0.co;2-w. Int J Cancer. 2000. PMID: 10842196

9

Status of activation of circulating vaccine-elicited CD8+ T cells.

Nielsen MB, Monsurro V, Migueles SA, Wang E, Perez-Diez A, Lee KH, Kammula U, Rosenberg SA, Marincola FM. Nielsen MB, et al. Among authors: kammula u. J Immunol. 2000 Aug 15;165(4):2287-96. doi: 10.4049/jimmunol.165.4.2287. J Immunol. 2000. PMID: 10925318

10

Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination.

Kammula US, Marincola FM, Rosenberg SA. Kammula US, et al. J Natl Cancer Inst. 2000 Aug 16;92(16):1336-44. doi: 10.1093/jnci/92.16.1336. J Natl Cancer Inst. 2000. PMID: 10944556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters